Latest News & Features
Big Pharma
Supplementary protection certificates are hugely important to MSD’s business, according to Elena Böhles, assistant counsel at the pharmaceutical company, based in Hertfordshire, UK. 16 November 2018
Asia-Pacific
Last year, for the first time in European Patent Office history, a Chinese company filed the most European patent applications, making an “impressive statement” on what companies in the country are doing, according to Peter Albrecht. 15 November 2018
Americas
The speed of technological advancements in the life sciences industry is forcing patent lawyers to consider whether the norms they’re used to dealing with in the profession still apply. 15 November 2018
Big Pharma
The UK Supreme Court’s decision in Warner-Lambert v Actavis is disappointing for pharmaceutical innovators, and enforcing second medical use patents may now be more challenging, lawyers have told LSIPR. 15 November 2018
Big Pharma
The UK Supreme Court today dismissed Warner-Lambert’s appeal in its pregabalin patent dispute with Actavis, while clarifying the role of plausibility in the sufficiency of patent applications. 14 November 2018
Americas
Quinn Emanuel Urquhart & Sullivan has hired IP life sciences partner Colleen James from Mayer Brown. 14 November 2018
Americas
Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis. 14 November 2018
Americas
Gene-editing company CRISPR Therapeutics has expanded its partnership with US-based MaxCyte, which focuses on cell-based medicines, into the immuno-oncology arena. 13 November 2018
Big Pharma
Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets. 12 November 2018
Africa
Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products. 12 November 2018